✦ LIBER ✦

Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from the p -Glycoprotein (ABCB1) Modulator Tariquidar

✍ Scribed by Kühnle, Matthias; Egger, Michael; Müller, Christine; Mahringer, Anne; Bernhardt, Günther; Fricker, Gert; König, Burkhard; Buschauer, Armin

Book ID: 120482634
Publisher: American Chemical Society
Year: 2009
Tongue: English
Weight: 192 KB
Volume: 52
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm8013822

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-glycoprotein (MDR1/ABCB1) and breast c

P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387

✍ Durmus, S.; Xu, N.; Sparidans, R.W.; Wagenaar, E.; Beijnen, J.H.; Schinkel, A.H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 957 KB

Interaction of drugs of abuse and mainte

Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)

✍ Tournier, Nicolas; Chevillard, Lucie; Megarbane, Bruno; Pirnay, Stéphane; Scherr 📂 Article 📅 2009 🏛 Cambridge University Press 🌐 English ⚖ 165 KB

Converting Potent Indeno[1,2- b ]indole

Converting Potent Indeno[1,2- b ]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2

✍ Jabor Gozzi, Gustavo; Bouaziz, Zouhair; Winter, Evelyn; Daflon-Yunes, Nathalia; 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 751 KB

Co-administration strategy to enhance br

Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors

✍ Mukul Minocha; Varun Khurana; Bin Qin; Dhananjay Pal; Ashim K. Mitra 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 934 KB

Influence of breast cancer resistance pr

Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood–brain barrier

✍ Sébastien Bihorel; Gian Camenisch; Michel Lemaire; Jean-Michel Scherrmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Brain accumulation of sunitinib is restr

Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration

✍ Seng Chuan Tang; Jurjen S. Lagas; Nienke A.G. Lankheet; Birk Poller; Michel J. H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 886 KB

## Abstract Sunitinib is an orally active, multitargeted tyrosine kinase inhibitor which has been used for the treatment of metastatic renal cell carcinoma and imatinib‐resistant gastrointestinal stromal tumors. We aimed to investigate the __in vivo__ roles of the ATP‐binding cassette drug efflux t